SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss of $34.7 million in its fiscal fourth quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 59 cents.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 73 cents per share.
The maker of synthetic DNA for the biotechnology industry posted revenue of $84.7 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $82.6 million.
For the year, the company reported a loss of $208.7 million, or $3.60 per share. Revenue was reported as $313 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TWST at https://www.zacks.com/ap/TWST
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。